← Eichor
Condition: Recurrent Mgmt Methylated Glioblastoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Mgmt Methylated Glioblastoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Phase 2/Phase 3 · 63 location(s) · Global Coalition for Adaptive Research · NCT03970447Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tum
Phase 1/Phase 2 · 36 location(s) · National Cancer Institute (NCI) · NCT05432804
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.